SkyKnight Capital has entered into a definitive agreement to invest in Apex Infusion, according to a news release.Apex, founded in 2006 and headquartered in Signal Hill, California, is an infusion provider that delivers therapies to patients across a network of ambulatory infusion suites and in-home care.SkyKnight Capital, founded in 2015 and with locations in Burlingame, California and New York, is a private equity firm focused on healthcare an…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.